EUROLAB
iso-10993-17-toxicological-risk-assessment
Claim Substantiation COLIPA Guidelines for Cosmetic Claim SupportEN 15886 Stability Testing of Cosmetic ProductsFDA Cosmetic Labeling Regulations TestingFDA Cosmetic Safety AssessmentFDA Cosmetic Safety Testing GuidanceFDA Guidance for Cosmetic Claim SubstantiationFDA Guidance on Cosmetic TestingFDA Voluntary Cosmetic Registration Program (VCRP) TestingISO 10993-10 Evaluation of Irritation and SensitizationISO 10993-10 Skin Irritation Testing for CosmeticsISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation for Safety TestingISO 10993-18 Chemical CharacterizationISO 10993-18 Chemical Characterization of CosmeticsISO 10993-19 Assessment of Allergic Contact DermatitisISO 10993-22 Sensitization TestISO 10993-22 Sensitization TestingISO 10993-23 Assessment of UV-induced PhototoxicityISO 10993-23 Phototoxicity TestingISO 10993-5 Cytotoxicity TestingISO 11930 Challenge Testing for PreservativesISO 11930 Preservative Efficacy Testing for ClaimsISO 11930-1 Challenge Testing for Preservative EfficacyISO 11930-2 Preservative Testing for Leave-on ProductsISO 11989 Validation of Microbiological MethodsISO 15193 Packaging Testing for ClaimsISO 16128 Natural and Organic Cosmetic Ingredient VerificationISO 16128 Natural Ingredient CalculationISO 16128-2 Natural and Organic Content CalculationISO 16128-3 Methodologies for Natural Cosmetic ClaimsISO 16134 Cosmetic Safety GuidelinesISO 16134 Guidelines for Cosmetics SafetyISO 16134-2 Patch Testing for DermatologyISO 16134-3 Patch Test for Dermatological ClaimsISO 16179 Testing of Antioxidants in CosmeticsISO 16212 Detection of Yeasts and Molds in Cosmetic ProductsISO 17516 Microbial Limits for Cosmetic ClaimsISO 17516 Microbial Quality TestingISO 17516 Microbial TestingISO 21148 Anaerobic Microorganism DetectionISO 21148 Detection of Anaerobic MicroorganismsISO 21149 Aerobic Bacteria EnumerationISO 21149 Enumeration of Aerobic Bacteria for Claim SupportISO 21150 Detection of Pathogens in CosmeticsISO 21150 Microbial Contamination TestingISO 21401 Environmental Impact TestingISO 21401 Environmental Label TestingISO 22715 Cosmetic Product Labelling ComplianceISO 22716 Cosmetic Good Manufacturing Practice Compliance TestingISO 22716 GMP for Cosmetic ProductsISO 24434 Antimicrobial Effectiveness TestingISO 24441 SPF Testing for Sun Care ProductsISO 24441 UVA Protection TestingISO 24442 Microbial Spores EnumerationISO 24442 Spore EnumerationISO 24443 UVA Protection TestingISO 24444 SPF Testing ProtocolISO 24444 Sun Protection Factor (SPF) TestingISO 24475 Microbiological Raw Material TestingISO 24475 Raw Material Microbiological TestingISO 24476 Guidelines for Microbiological MethodsISO 24476 Guidelines for Microbiological TestingISO 31661 Photostability TestingISO 31661-2 UV Stability TestingOECD TG 405 In Vivo Eye Irritation TestingOECD TG 431 In Vitro Skin Corrosion TestingOECD TG 439 In Vitro Skin Irritation Testing for ClaimsOECD TG 442C In Vitro Skin SensitizationOECD TG 442D In Vitro Skin Sensitization Assay

Comprehensive Guide to ISO 10993-17 Toxicological Risk Assessment Laboratory Testing Service Provided by Eurolab

ISO 10993-17 is a part of the International Organization for Standardization (ISO) 10993 series, which provides guidelines for the biological evaluation of medical devices. Specifically, ISO 10993-17 focuses on the toxicological risk assessment of medical devices using in vitro methods.

Relevant Standards

  • ISO 10993-1:2018: Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
  • ISO 10993-3:2014: Biological evaluation of medical devices Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • ASTM F2025-14: Standard Guide for Characterization of In Vitro Cytotoxicity Results
  • Legal and Regulatory Framework

    The European Unions Medical Device Regulation (MDR) 2017/745 requires manufacturers to conduct a risk assessment on their medical devices, including toxicological evaluation. ISO 10993-17 is widely accepted as the standard for in vitro cytotoxicity testing.

    International and National Standards

  • US FDA: Guidance for Industry Software as a Medical Device (SaMD): Clinical Evaluation
  • Japanese Ministry of Health, Labour and Welfare (MHLW): Standard for Biological Testing of Medical Devices
  • Standard Development Organizations

    The ISO 10993 series is developed by the Technical Committee 194 (TC 194) on Implants for Surgery. The committee consists of experts from various countries, including Europe, North America, and Asia.

    Evolution and Updates

    Standards evolve through continuous review and updates to ensure they remain relevant and effective. New standards are developed in response to advances in technology, changes in regulations, or emerging issues.

    Specific Standard Numbers and Scope

  • ISO 10993-17:2018 Toxicological risk assessment for medical devices using in vitro methods
  • ISO 10993-1:2018 Evaluation and testing within a risk management process
  • Standard Compliance Requirements

    Manufacturers must comply with relevant standards to ensure their products meet regulatory requirements. Non-compliance can result in product recalls, fines, or even legal action.

  • Regulatory bodies: EU, US FDA, Japanese MHLW
  • Industry sectors: Medical devices, pharmaceuticals, cosmetics
  • Compliance requirements: ISO 10993-17, ASTM F2025-14, US FDA guidance
  • Why This Test is Needed and Required

    The toxicological risk assessment of medical devices using in vitro methods is essential for ensuring product safety. The test assesses the potential cytotoxic effects of materials on human cells.

    Business and Technical Reasons for Conducting ISO 10993-17 Testing

  • Compliance with regulatory requirements
  • Ensuring product safety and reliability
  • Meeting customer expectations and building trust
  • Consequences of Not Performing this Test

    Non-compliance with standards can result in costly recalls, fines, or even legal action. Manufacturers risk damaging their reputation and losing customer confidence.

    Industries and Sectors that Require This Testing

  • Medical devices: Implants, instruments, disposables
  • Pharmaceuticals: Formulations, excipients, packaging materials
  • Cosmetics: Raw materials, finished products
  • Risk Factors and Safety Implications

    Cytotoxic effects can lead to adverse reactions in humans. Manufacturers must ensure their products are safe for use.

    Quality Assurance and Quality Control Aspects

    Manufacturers must implement quality management systems (QMS) to ensure consistent product quality and regulatory compliance.

    Detailed Step-by-Step Explanation of How the Test is Conducted

    1. Sample preparation: Preparation of test samples according to ISO 10993-17 guidelines

    2. Cell culture: In vitro cell culture using human dermal fibroblasts or other relevant cell lines

    3. Cytotoxicity testing: Testing for cytotoxic effects on cells using MTT, XTT, or other suitable assays

    4. Data analysis: Statistical analysis of results to determine cytotoxic potency

    Testing Equipment and Instruments Used

  • Microplate reader
  • Incubator
  • Centrifuge
  • Pipettes and tips
  • Testing Environment Requirements (Temperature, Humidity, Pressure)

  • Temperature: 37C 1C
  • Humidity: 60 10
  • Pressure: Atmospheric pressure
  • Sample Preparation Procedures

    Samples must be prepared according to ISO 10993-17 guidelines.

    Testing Parameters and Conditions

  • Cytotoxicity testing using MTT, XTT, or other suitable assays
  • Concentration range: 0.1 mg/mL 100 mg/mL
  • Incubation time: 24 hours 2 hours
  • Measurement and Analysis Methods

  • MTT reduction assay for measuring cell viability
  • Statistical analysis of results to determine cytotoxic potency
  • Sample preparation: Preparation of test samples according to ISO 10993-17 guidelines
  • Cell culture: In vitro cell culture using human dermal fibroblasts or other relevant cell lines
  • Cytotoxicity testing: Testing for cytotoxic effects on cells using MTT, XTT, or other suitable assays
  • Quality Assurance and Quality Control Aspects

    Manufacturers must implement quality management systems (QMS) to ensure consistent product quality and regulatory compliance.

    Why Choose Eurolabs ISO 10993-17 Testing Service?

    Our expert team provides reliable and accurate results using state-of-the-art equipment. We offer:

  • Compliance with regulatory requirements
  • Ensuring product safety and reliability
  • Meeting customer expectations and building trust
  • Conclusion

    ISO 10993-17 is an essential standard for the toxicological risk assessment of medical devices using in vitro methods. Manufacturers must ensure their products meet regulatory requirements to avoid costly recalls, fines, or even legal action.

    The test assesses the potential cytotoxic effects of materials on human cells and ensures product safety and reliability.

    Eurolabs ISO 10993-17 testing service provides reliable and accurate results using state-of-the-art equipment. Our expert team is dedicated to ensuring compliance with regulatory requirements and meeting customer expectations.

    By choosing Eurolabs ISO 10993-17 testing service, manufacturers can ensure their products are safe for use and meet the highest standards of quality and reliability.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers